{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:19Z","timestamp":1791928939869,"version":"4.3.4"},"reference-count":51,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,11,24]]},"DOI":"10.1167\/iovs.66.14.58","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T14:30:32Z","timestamp":1763994632000},"page":"58","source":"Crossref","is-referenced-by-count":1,"title":["Preclinical Assessment of Mitochondrial-Targeted\n                    <i>ND4<\/i>\n                    Gene Therapy for Leber Hereditary Optic Neuropathy"],"prefix":"10.1167","volume":"66","author":[{"given":"Yingjia","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China"},{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Hao","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqin","family":"Chang","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Porciatti","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron L.","family":"Lam","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yu","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"5407","key":"bib1","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"},{"issue":"1","key":"bib2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ana.25127","article-title":"Pathological mechanisms underlying single large-scale mitochondrial DNA deletions","volume":"83","author":"Rocha","year":"2018","journal-title":"Ann Neurol"},{"issue":"3","key":"bib3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tig.2019.01.001","article-title":"Mechanisms of mitochondrial DNA deletion formation","volume":"35","author":"Nissanka","year":"2019","journal-title":"Trends Genet"},{"issue":"5","key":"bib5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/ICU.0000000000000410","article-title":"Leber hereditary optic neuropathy: bridging the translational gap","volume":"28","author":"Jurkute","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"bib6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1177\/1120672120936592","article-title":"Treatment of Leber's hereditary optic neuropathy: an overview of recent developments","volume":"30","author":"Zuccarelli","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"bib7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ana.10354","article-title":"Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy","volume":"52","author":"Guy","year":"2002","journal-title":"Ann Neurol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"21587","DOI":"10.1038\/srep21587","article-title":"Efficacy and safety of rAAV2-ND4 treatment for Leber's hereditary optic neuropathy","volume":"6","author":"Wan","year":"2016","journal-title":"Sci Rep"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"bib10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/ceo.13515","article-title":"Prognostic factors for visual acuity in patients with Leber's hereditary optic neuropathy after rAAV2-ND4 gene therapy","volume":"47","author":"Zhang","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"bib11","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1111\/aos.14379","article-title":"Factors associated with rapid improvement in visual acuity in patients with Leber's hereditary optic neuropathy after gene therapy","volume":"98","author":"Liu","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"bib12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/WNO.0000000000001367","article-title":"Long-term follow-up after unilateral intravitreal gene therapy for Leber hereditary optic neuropathy: the RESTORE Study","volume":"41","author":"Biousse","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"662838","DOI":"10.3389\/fneur.2021.662838","article-title":"Intravitreal gene therapy vs. natural history in patients with Leber hereditary optic neuropathy carrying the m.11778G&gt;A ND4 mutation: systematic review and indirect comparison","volume":"12","author":"Newman","year":"2021","journal-title":"Front Neurol"},{"issue":"5","key":"bib14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"bib15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40259-021-00468-9","article-title":"Safety of intravitreal gene therapy for treatment of subjects with Leber hereditary optic neuropathy due to mutations in the mitochondrial ND4 gene: the REVEAL study","volume":"35","author":"Vignal-Clermont","year":"2021","journal-title":"BioDrugs"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ajo.2022.02.023","article-title":"Leber hereditary optic neuropathy gene therapy: adverse events and visual acuity results of all patient groups","volume":"241","author":"Lam","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"bib17","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S1525-0016(16)34609-3","article-title":"AAV integrates randomly into the nuclear and mitochondrial genome after LPLD gene therapy","volume":"21","author":"Kaeppel","year":"2013","journal-title":"Mol Ther"},{"issue":"20","key":"bib18","doi-asserted-by":"publisher","first-page":"E1238","DOI":"10.1073\/pnas.1119577109","article-title":"Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"42","key":"bib19","doi-asserted-by":"publisher","first-page":"E5689","DOI":"10.1073\/pnas.1506129112","article-title":"Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in mice","volume":"112","author":"Yu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"1119724","DOI":"10.3389\/fnins.2023.1119724","article-title":"Comparison of different gene-therapy methods to treat Leber hereditary optic neuropathy in a mouse model","volume":"17","author":"Velmurugan","year":"2023","journal-title":"Front Neurosci"},{"issue":"3","key":"bib21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for Leber hereditary optic neuropathy: initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"issue":"11","key":"bib22","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","article-title":"Gene therapy for Leber hereditary optic neuropathy: low- and medium-dose visual results","volume":"124","author":"Guy","year":"2017","journal-title":"Ophthalmology"},{"issue":"4","key":"bib23","doi-asserted-by":"publisher","first-page":"112265","DOI":"10.1016\/j.isci.2025.112265","article-title":"The clinical safety landscape for ocular AAV gene therapies: a systematic review and meta-analysis","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"109638","DOI":"10.1016\/j.exer.2023.109638","article-title":"Quantitative intravitreal pharmacokinetics in mouse as a step towards inter-species translation","volume":"235","author":"Puranen","year":"2023","journal-title":"Exp Eye Res"},{"issue":"10","key":"bib25","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1021\/acs.molpharmaceut.9b00679","article-title":"Intravitreal pharmacokinetics in mice: SPECT\/CT imaging and scaling to rabbits and humans","volume":"16","author":"Schmitt","year":"2019","journal-title":"Mol Pharm"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"105720","DOI":"10.1016\/j.ejps.2021.105720","article-title":"Pharmacokinetics of intravitreal macromolecules: scaling between rats and rabbits","volume":"159","author":"Sadeghi","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data","volume":"137","author":"Del Amo","year":"2015","journal-title":"Exp Eye Res"},{"issue":"12","key":"bib28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/gt.2017.85","article-title":"Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina","volume":"24","author":"Hickey","year":"2017","journal-title":"Gene Ther"},{"issue":"2","key":"bib29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jviromet.2006.06.011","article-title":"Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR","volume":"137","author":"Mayginnes","year":"2006","journal-title":"J Virol Methods"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.6.3.5","article-title":"Next generation PERG method: expanding the response dynamic range and capturing response adaptation","volume":"6","author":"Monsalve","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-0716-3409-7","article-title":"Optical coherence tomography: imaging visual system structures in mice","volume":"2708","author":"Liu","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"4","key":"bib32","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1167\/iovs.06-0815","article-title":"In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography","volume":"48","author":"Ruggeri","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bib33","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1167\/iovs.05-0996","article-title":"Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes","volume":"47","author":"Levkovitch-Verbin","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"bib34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1679\/aohc1950.40.321","article-title":"Electron microscopy of the mouse optic nerve: a quantitative study of the total optic nerve fibers","volume":"40","author":"Honjin","year":"1977","journal-title":"Arch Histol Jpn"},{"issue":"10","key":"bib35","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"4","key":"bib36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jamaophthalmol.2013.7630","article-title":"Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial","volume":"132","author":"Koilkonda","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"bib37","doi-asserted-by":"publisher","first-page":"18396","DOI":"10.1038\/s41598-019-54930-4","article-title":"Adaptation of retinal ganglion cell function during flickering light in the mouse","volume":"9","author":"Chou","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"bib38","doi-asserted-by":"publisher","first-page":"101437","DOI":"10.1016\/j.xcrm.2024.101437","article-title":"Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial","volume":"5","author":"Yu-Wai-Man","year":"2024","journal-title":"Cell Rep Med"},{"issue":"4","key":"bib39","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/brain\/awac421","article-title":"Randomized trial of bilateral gene therapy injection for m.11778G&gt;A MT-ND4 Leber optic neuropathy","volume":"146","author":"Newman","year":"2023","journal-title":"Brain"},{"issue":"573","key":"bib40","doi-asserted-by":"publisher","first-page":"eaaz7423","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci Transl Med"},{"issue":"2","key":"bib41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/mt.2011.237","article-title":"Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector","volume":"20","author":"Bowles","year":"2012","journal-title":"Mol Ther"},{"issue":"24","key":"bib42","doi-asserted-by":"publisher","first-page":"E4812","DOI":"10.1073\/pnas.1704766114","article-title":"Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion","volume":"114","author":"Tse","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jviromet.2016.07.009","article-title":"Generation and characterization of anti-adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies","volume":"236","author":"Tseng","year":"2016","journal-title":"J Virol Methods"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"108545","DOI":"10.1016\/j.exer.2021.108545","article-title":"The internal limiting membrane: roles in retinal development and implications for emerging ocular therapies","volume":"206","author":"Zhang","year":"2021","journal-title":"Exp Eye Res"},{"issue":"8","key":"bib45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1089\/hum.2016.085","article-title":"Highly efficient delivery of adeno-associated viral vectors to the primate retina","volume":"27","author":"Boye","year":"2016","journal-title":"Hum Gene Ther"},{"key":"bib46","first-page":"1771","article-title":"Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2","volume":"17","author":"Cehajic-Kapetanovic","year":"2011","journal-title":"Mol Vis"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-9139-6","article-title":"SubILM injection of AAV for Gene Delivery to the Retina","volume":"1950","author":"Gamlin","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"2","key":"bib48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/mt.2010.234","article-title":"Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina","volume":"19","author":"Petrs-Silva","year":"2011","journal-title":"Mol Ther"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2024.06.029","article-title":"Utilizing extracellular vesicles as a drug delivery system in glaucoma and RGC degeneration","volume":"372","author":"Durmaz","year":"2024","journal-title":"J Control Release"},{"issue":"189","key":"bib50","doi-asserted-by":"publisher","first-page":"189ra176","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci Transl Med"},{"issue":"21","key":"bib51","doi-asserted-by":"publisher","first-page":"9878","DOI":"10.1128\/JVI.01568-16","article-title":"Heparan sulfate binding promotes accumulation of intravitreally delivered adeno-associated viral vectors at the retina for enhanced transduction but weakly influences tropism","volume":"90","author":"Woodard","year":"2016","journal-title":"J Virol"},{"key":"bib4","article-title":"Leber hereditary optic neuropathy","volume-title":"GeneReviews((R))","author":"Yu-Wai-Man","year":"1993"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:08Z","timestamp":1791927128000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":51,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.14.58","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}